Bio Rad实验室-A 2025年度报告

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days.Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 ofthe Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrantincluded in the filing reflect the correction of an error to previously issued financial statements. Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). As of June 30, 2025, the last business day of the registrant's most recently completed second fiscal quarter, the aggregate market value of the Registrant's Class ACommon Stock held by non-affiliates was approximately $4,446,568,594 and the aggregate market value of the registrant's Class B Common Stock held by non-affiliates was approximately $23,786,912. As of February9, 2026, there were 21,924,284 shares of Class A Common Stock and 5,066,110 shares of Class B Common Stock outstanding. Form 10-K Parts BIO-RAD LABORATORIES, INC. FORM 10-K DECEMBER31, 2025 TABLE OF CONTENTS Part I.3Item 1. Business3Item 1A. Risk Factors10Item 1B. Unresolved Staff Comments23Item 1C. Cybersecurity24Item 2. Properties25Item 3. Legal Proceedings26Item 4. Mine Safety Disclosures26Part II.26Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of EquitySecurities26Item 6. Reserved27Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations27Item 7A. Quantitative and Qualitative Disclosures About Market Risk34Item 8. Financial Statements and Supplementary Data36Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure87Item 9A. Controls and Procedures87Item 9B. Other Information89Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections89Part III.89Item 10. Directors, Executive Officers and Corporate Governance89Item 11. Executive Compensation90Item 12.Security Ownership of Certain Beneficial Ownersand Management and Related Stockholder Matters90Item 13. Certain Relationships and Related Transactions, and Director Independence90Item 14. Principal Accountant Fees and Services90Part IV.91Item 15. Exhibits and Financial Statement Schedules91Item 16. Form 10-K Summary94Signatures94 INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS Other than statements of historical fact, statements made in this report include forward-looking statements, within themeaning of the Private Securities Litigation Reform Act of 1995.These forward-looking statements include, withoutlimitation, statements we make regarding our future financial performance, operating results, plans and objectives.Forward-looking statements generally can be identified by the use of forward-looking terminology, such as “believe,”“expect,” “anticipate,” “may,” “will,” “intend,” “estimate,” “continue,” “seek,” “future,” or similar expressions or thenegative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results tovary materially from those expressed in or indicated by the forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. However, actual results may differmaterially from those currently anticipated depending on a variety of risk factors including, but not limited to, the risksrelating to our international operations, global economic and geopolit